Finland· FI-REL-REL65084
Twinrix Adult
A kombinationen (hepatitis a + hepatitis b) product containing hepatitis a virus, whole virus, inactivated + hepatitis b virus, surface antigen, rdna, registered in Finland by Paranova Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Hepatitis A virus, whole virus, inactivated + Hepatitis B virus, surface antigen, rDNA
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- J07BC20
- ATC class
- Kombinationen (Hepatitis A + Hepatitis B)
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BC20
Kombinationen (hepatitis a + hepatitis b), as other registers publish it.
- IcelandAmbirixGlaxoSmithKline Biologicals S.A.*
- DenmarkAmbirixGlaxoSmithKline Biologicals S.A.
- BelgiumAmbirixGlaxoSmithKline Biologicals
- PolandAmbirixGlaxoSmithKline Biologicals S.A.
- FinlandAmbirixGlaxoSmithKline Biologicals S.A.
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
- CzechiaAMBIRIXGlaxoSmithKline Biologicals S.A., Rixensart
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b81af74e-775b-40bf-a1e7-5420a161ce2e GET /v1/drugs/b81af74e-775b-40bf-a1e7-5420a161ce2e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio, esitäytetty ruisku",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "yhdistelmävalmisteet",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/96/020/007",
"fimea_rel_id": "REL65084",
"authorised_at": "2026-02-27"
}See everything about kombinationen (hepatitis a + hepatitis b).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.